The chimeric RNAs generated from tripartite motif containing 46 (TRIM46) with MUC1 and KRTCAP2 have been clinically implicated in high-grade serous ovarian carcinoma (Kannan et al., 2015). This evidence concerns the gene KRTCAP2 and ovarian serous carcinoma.